Pfizer to buy biotech group Biohaven for $11.6bn | Financial Times
US pharmaceutical group’s biggest deal in more than 5 years comes as sales of its Covid vaccine are set to fall
✒ Putting the once-in-a-lifetime Covid cash windfall to work. Expect more deals to come.